Skip to main content
Top
Published in: Lung 3/2010

01-06-2010

Levels of Dihydrotestosterone, Testosterone, Androstenedione, and Estradiol in Canalicular, Saccular, and Alveolar Mouse Lungs

Authors: Eric Boucher, Pierre R. Provost, Audrey Devillers, Yves Tremblay

Published in: Lung | Issue 3/2010

Login to get access

Abstract

Androgens and estrogens are known regulators of fetal and postnatal lung development, but their levels in the developing lung have never been determined. We present here, for the first time, a gas chromatography-mass spectrometry (GC/MS) quantification of dihydrotestosterone, testosterone, androstenedione, and estradiol in canalicular, saccular, and alveolar stage lungs of both sexes. Testosterone, androstenedione, and estradiol were observed in all the analyzed lung samples from gestation day (GD) 16.5 to postnatal day (PN) 30, totalizing 383 individual mice. Levels of these three steroids decreased between birth and PN 5. In contrast, dihydrotestosterone was detected only in male samples on GD 19.5, PN 0, and PN 30. A significant sex difference was observed for testosterone and androstenedione but not for estradiol. Steroid levels were also determined in skinned hind legs for comparison. Three-way analysis of variance revealed that tissue (lung or leg) had a significant effect on testosterone levels for both sexes, but not on androstenedione and estradiol levels. Low but significant testosterone and androstenedione levels were observed in all the females and in prepubertal male samples. These levels must be sufficient to induce androgen receptor activation, as suggested by our recent report showing the presence of androgen receptor in the nucleus of several lung cells in corresponding developmental ages and sexes.
Literature
1.
go back to reference Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC (2007) The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 293:L272–L278CrossRefPubMed Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC (2007) The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 293:L272–L278CrossRefPubMed
2.
go back to reference Nielsen HC, Zinman HM, Torday JS (1982) Dihydrotestosterone inhibits fetal rabbit pulmonary surfactant production. J Clin Invest 69:611–616CrossRefPubMed Nielsen HC, Zinman HM, Torday JS (1982) Dihydrotestosterone inhibits fetal rabbit pulmonary surfactant production. J Clin Invest 69:611–616CrossRefPubMed
3.
go back to reference Rodriguez A, Viscardi RM, Torday JS (2001) Fetal androgen exposure inhibits fetal rat lung fibroblast lipid uptake and release. Exp Lung Res 27:13–24CrossRefPubMed Rodriguez A, Viscardi RM, Torday JS (2001) Fetal androgen exposure inhibits fetal rat lung fibroblast lipid uptake and release. Exp Lung Res 27:13–24CrossRefPubMed
4.
go back to reference Kimura Y, Suzuki T, Kaneko C, Darnel AD, Akahira J, Ebina M, Nukiwa T, Sasano H (2003) Expression of androgen receptor and 5alpha-reductase types 1 and 2 in early gestation fetal lung: a possible correlation with branching morphogenesis. Clin Sci (Lond) 105:709–713CrossRef Kimura Y, Suzuki T, Kaneko C, Darnel AD, Akahira J, Ebina M, Nukiwa T, Sasano H (2003) Expression of androgen receptor and 5alpha-reductase types 1 and 2 in early gestation fetal lung: a possible correlation with branching morphogenesis. Clin Sci (Lond) 105:709–713CrossRef
5.
go back to reference Levesque BM, Vosatka RJ, Nielsen HC (2000) Dihydrotestosterone stimulates branching morphogenesis, cell proliferation, and programmed cell death in mouse embryonic lung explants. Pediatr Res 47:481–491CrossRefPubMed Levesque BM, Vosatka RJ, Nielsen HC (2000) Dihydrotestosterone stimulates branching morphogenesis, cell proliferation, and programmed cell death in mouse embryonic lung explants. Pediatr Res 47:481–491CrossRefPubMed
6.
go back to reference Adamson IY, Bakowska J, McMillan E, King GM (1990) Accelerated fetal lung maturation by estrogen is associated with an epithelial-fibroblast interaction. In Vitro Cell Dev Biol 26:784–790CrossRefPubMed Adamson IY, Bakowska J, McMillan E, King GM (1990) Accelerated fetal lung maturation by estrogen is associated with an epithelial-fibroblast interaction. In Vitro Cell Dev Biol 26:784–790CrossRefPubMed
7.
go back to reference Chu AJ, Rooney SA (1985) Estrogen stimulation of surfactant synthesis. Pediatr Pulmonol 1:S110–S114PubMed Chu AJ, Rooney SA (1985) Estrogen stimulation of surfactant synthesis. Pediatr Pulmonol 1:S110–S114PubMed
8.
go back to reference Massaro D, Massaro GD (2004) Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol 287:L1154–L1159CrossRefPubMed Massaro D, Massaro GD (2004) Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol 287:L1154–L1159CrossRefPubMed
9.
go back to reference Trotter A, Ebsen M, Kiossis E, Meggle S, Kueppers E, Beyer C, Pohlandt F, Maier L, Thome UH (2006) Prenatal estrogen and progesterone deprivation impairs alveolar formation and fluid clearance in newborn piglets. Pediatr Res 60:60–64CrossRefPubMed Trotter A, Ebsen M, Kiossis E, Meggle S, Kueppers E, Beyer C, Pohlandt F, Maier L, Thome UH (2006) Prenatal estrogen and progesterone deprivation impairs alveolar formation and fluid clearance in newborn piglets. Pediatr Res 60:60–64CrossRefPubMed
10.
go back to reference Massaro D, Massaro GD (2006) Estrogen receptor regulation of pulmonary alveolar dimensions: alveolar sexual dimorphism in mice. Am J Physiol Lung Cell Mol Physiol 290:L866–L870CrossRefPubMed Massaro D, Massaro GD (2006) Estrogen receptor regulation of pulmonary alveolar dimensions: alveolar sexual dimorphism in mice. Am J Physiol Lung Cell Mol Physiol 290:L866–L870CrossRefPubMed
11.
go back to reference O’Shaughnessy PJ, Baker PJ, Heikkila M, Vainio S, McMahon AP (2000) Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis—androstenedione is the major androgen secreted by fetal/neonatal leydig cells. Endocrinology 141:2631–2637CrossRefPubMed O’Shaughnessy PJ, Baker PJ, Heikkila M, Vainio S, McMahon AP (2000) Localization of 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase isoform expression in the developing mouse testis—androstenedione is the major androgen secreted by fetal/neonatal leydig cells. Endocrinology 141:2631–2637CrossRefPubMed
12.
go back to reference Barkley MS, Geschwind II, Bradford GE (1979) The gestational pattern of estradiol, testosterone and progesterone secretion in selected strains of mice. Biol Reprod 20:733–738CrossRefPubMed Barkley MS, Geschwind II, Bradford GE (1979) The gestational pattern of estradiol, testosterone and progesterone secretion in selected strains of mice. Biol Reprod 20:733–738CrossRefPubMed
13.
go back to reference Wong L, Spearow JL, Castracane VD, Barkley M (1995) Genetic variation in plasma androgens and ovarian aromatase activity during mouse pregnancy. Proc Soc Exp Biol Med 208:277–282PubMed Wong L, Spearow JL, Castracane VD, Barkley M (1995) Genetic variation in plasma androgens and ovarian aromatase activity during mouse pregnancy. Proc Soc Exp Biol Med 208:277–282PubMed
14.
go back to reference Stahl F, Gotz F, Dorner G (1991) The influence of fetal adrenals on the androgen levels during brain differentiation in human subjects and rats. Exp Clin Endocrinol 98:131–139CrossRefPubMed Stahl F, Gotz F, Dorner G (1991) The influence of fetal adrenals on the androgen levels during brain differentiation in human subjects and rats. Exp Clin Endocrinol 98:131–139CrossRefPubMed
15.
go back to reference Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O, Vainio S (2002) Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143:4358–4365CrossRefPubMed Heikkila M, Peltoketo H, Leppaluoto J, Ilves M, Vuolteenaho O, Vainio S (2002) Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production. Endocrinology 143:4358–4365CrossRefPubMed
16.
go back to reference Zoetis T, Hurtt ME (2003) Species comparison of lung development. Birth Defects Res B Dev Reprod Toxicol 68:121–124CrossRefPubMed Zoetis T, Hurtt ME (2003) Species comparison of lung development. Birth Defects Res B Dev Reprod Toxicol 68:121–124CrossRefPubMed
17.
go back to reference Motelica-Heino I, Castanier M, Corbier P, Edwards DA, Roffi J (1988) Testosterone levels in plasma and testes of neonatal mice. J Steroid Biochem 31:283–286CrossRefPubMed Motelica-Heino I, Castanier M, Corbier P, Edwards DA, Roffi J (1988) Testosterone levels in plasma and testes of neonatal mice. J Steroid Biochem 31:283–286CrossRefPubMed
18.
go back to reference Boucher E, Provost PR, Plante J, Tremblay Y (2009) Androgen receptor and 17beta-HSD type 2 regulation in neonatal mouse lung development. Mol Cell Endocrinol 311:109–119CrossRefPubMed Boucher E, Provost PR, Plante J, Tremblay Y (2009) Androgen receptor and 17beta-HSD type 2 regulation in neonatal mouse lung development. Mol Cell Endocrinol 311:109–119CrossRefPubMed
19.
go back to reference Drolet R, Simard M, Plante J, Laberge P, Tremblay Y (2007) Human type 2 17 beta-hydroxysteroid dehydrogenase mRNA and protein distribution in placental villi at mid and term pregnancy. Reprod Biol Endocrinol 5:30CrossRefPubMed Drolet R, Simard M, Plante J, Laberge P, Tremblay Y (2007) Human type 2 17 beta-hydroxysteroid dehydrogenase mRNA and protein distribution in placental villi at mid and term pregnancy. Reprod Biol Endocrinol 5:30CrossRefPubMed
20.
go back to reference Labrie F, Belanger A, Belanger P, Berube R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J (2006) Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182–188CrossRefPubMed Labrie F, Belanger A, Belanger P, Berube R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J (2006) Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 99:182–188CrossRefPubMed
21.
go back to reference Hanley K, Rassner U, Jiang Y, Vansomphone D, Crumrine D, Komuves L, Elias PM, Feingold KR, Williams ML (1996) Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest 97:2576–2584CrossRefPubMed Hanley K, Rassner U, Jiang Y, Vansomphone D, Crumrine D, Komuves L, Elias PM, Feingold KR, Williams ML (1996) Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest 97:2576–2584CrossRefPubMed
22.
go back to reference Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold KR, Elias PM (2001) Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 116:443–451CrossRefPubMed Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold KR, Elias PM (2001) Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 116:443–451CrossRefPubMed
23.
go back to reference Ellsworth K, Harris G (1995) Expression of the type 1 and 2 steroid 5 alpha-reductases in human fetal tissues. Biochem Biophys Res Commun 215:774–780CrossRefPubMed Ellsworth K, Harris G (1995) Expression of the type 1 and 2 steroid 5 alpha-reductases in human fetal tissues. Biochem Biophys Res Commun 215:774–780CrossRefPubMed
24.
go back to reference O’Shaughnessy PJ, Baker PJ, Johnston H (2006) The foetal Leydig cell—differentiation, function and regulation. Int J Androl 29:90–95; discussion 105-108 O’Shaughnessy PJ, Baker PJ, Johnston H (2006) The foetal Leydig cell—differentiation, function and regulation. Int J Androl 29:90–95; discussion 105-108
25.
go back to reference Habert R, Picon R (1984) Testosterone, dihydrotestosterone and estradiol-17 beta levels in maternal and fetal plasma and in fetal testes in the rat. J Steroid Biochem 21:193–198CrossRefPubMed Habert R, Picon R (1984) Testosterone, dihydrotestosterone and estradiol-17 beta levels in maternal and fetal plasma and in fetal testes in the rat. J Steroid Biochem 21:193–198CrossRefPubMed
26.
go back to reference Plante J, Simard M, Rantakari P, Cote M, Provost PR, Poutanen M, Tremblay Y (2009) Epithelial cells are the major site of hydroxysteroid (17beta) dehydrogenase 2 and androgen receptor expression in fetal mouse lungs during the period overlapping the surge of surfactant. J Steroid Biochem Mol Biol 117:139–145CrossRefPubMed Plante J, Simard M, Rantakari P, Cote M, Provost PR, Poutanen M, Tremblay Y (2009) Epithelial cells are the major site of hydroxysteroid (17beta) dehydrogenase 2 and androgen receptor expression in fetal mouse lungs during the period overlapping the surge of surfactant. J Steroid Biochem Mol Biol 117:139–145CrossRefPubMed
27.
go back to reference Provost PR, Simard M, Tremblay Y (2004) A link between lung androgen metabolism and the emergence of mature epithelial type II cells. Am J Respir Crit Care Med 170:296–305CrossRefPubMed Provost PR, Simard M, Tremblay Y (2004) A link between lung androgen metabolism and the emergence of mature epithelial type II cells. Am J Respir Crit Care Med 170:296–305CrossRefPubMed
28.
go back to reference Tremblay Y, Provost PR (2006) 17Beta-HSD type 5 expression and the emergence of differentiated epithelial type II cells in fetal lung: a novel role for androgen during the surge of surfactant. Mol Cell Endocrinol 248:118–125CrossRefPubMed Tremblay Y, Provost PR (2006) 17Beta-HSD type 5 expression and the emergence of differentiated epithelial type II cells in fetal lung: a novel role for androgen during the surge of surfactant. Mol Cell Endocrinol 248:118–125CrossRefPubMed
29.
go back to reference Provost PR, Boucher E, Tremblay Y (2009) Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids. J Endocrinol 200:321–330CrossRefPubMed Provost PR, Boucher E, Tremblay Y (2009) Apolipoprotein A-I, A-II, C-II, and H expression in the developing lung and sex difference in surfactant lipids. J Endocrinol 200:321–330CrossRefPubMed
30.
go back to reference Plante J, Simard M, Rantakari P, Cote M, Provost PR, Poutanen M, Tremblay Y (2009) Epithelial cells are the major site of hydroxysteroid (17beta) dehydrogenase 2 and androgen receptor expression in fetal mouse lungs during the period overlapping the surge of surfactant. J Steroid Biochem Mol Biol 117:139–145CrossRefPubMed Plante J, Simard M, Rantakari P, Cote M, Provost PR, Poutanen M, Tremblay Y (2009) Epithelial cells are the major site of hydroxysteroid (17beta) dehydrogenase 2 and androgen receptor expression in fetal mouse lungs during the period overlapping the surge of surfactant. J Steroid Biochem Mol Biol 117:139–145CrossRefPubMed
31.
go back to reference Provost PR, Tremblay Y (2007) Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. J Steroid Biochem Mol Biol 103:61–64CrossRefPubMed Provost PR, Tremblay Y (2007) Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. J Steroid Biochem Mol Biol 103:61–64CrossRefPubMed
Metadata
Title
Levels of Dihydrotestosterone, Testosterone, Androstenedione, and Estradiol in Canalicular, Saccular, and Alveolar Mouse Lungs
Authors
Eric Boucher
Pierre R. Provost
Audrey Devillers
Yves Tremblay
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Lung / Issue 3/2010
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-010-9231-x

Other articles of this Issue 3/2010

Lung 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine